| 7-AAD | 7-amino-actinomycin D |
| AD | Alzheimer’s Diseases |
| APC | Allophycocyanin |
| ADHD | Attention deficit/hyperactivity disorder |
| ASD | Autism spectrum disorder |
| BSA | bovine serum albumin |
| CNS | Central nervous system |
| ConA | Concanavalin A |
| DLNs | Draining lymph nodes |
| DMEM | Dulbecco’s Modified Eagle Medium |
| DMF | Dimethylfumarate |
| EAE | Experimental autoimmune encephalomyelitis |
| FBS | Fetal bovine serum |
| FCS | Fetal Calf Serum |
| FTY720 | Fingolimod |
| GBSS | Gey’s balanced salt solution |
| HACTV | Horizontal activity |
| HBSS | Hank’s Balanced Salt Solution |
| HDAC1/2 | Histone deacetylase 1 and 2 |
| HPβCD | hydroxypropyl-β-cyclodextrin |
| IC50 | Inhibitory concentration 50 |
| KDM1A | Lysine (K)-specific demethylase 1A |
| LSD1 | Lysine specific demethylase |
| MAO-B | Monoamine oxidase B |
| MEM | Minimal essential medium |
| MOG35–55 | Myelin oligodendrocyte glycoprotein |
| MPP+ | 1-methyl-4-phenylpyridinium |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MS | Multiple sclerosis |
| OCT | Optimal cutting temperature compound |
| ORY-1001 | Iadademstat |
| ORY-2001 | Vafidemstat |
| ORY-LSD1 | LSD1 selective inhibitor |
| PBS | Phosphate bufferd saline |
| PE | Phycoerythrin |
| PFU | Plaque forming units |
| PVP-40 | Polyvinylpyrrolidone-40 |
| RCOR | REST corepressor |
| S1PRs | Sphingosine 1 phosphate receptors |
| SAMP8 | Senescence accelerated mouse prone 8 |
| SAHA | Suberoylanilide hydroxamic acid |
| TBS | Tris buffered saline |
| TCP | Tranylcypromine |
| THA | DL-threo-β-hydroxyaspartic |
| TLR4 | Toll-Like Receptor 4 |
| TMEV | Theiler’s murine encephalomyelitis virus |
| TSA | Trichostatin A |
| VACTV | Vertical activity |